2500-2236

Microbiology Independent Research Journal (MIR Journal)

Doctrine

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 72 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact72 DOIs
2

Add abstracts to 21 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact21 DOIs
3

Deposit reference lists for 14 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact14 DOIs

DOIs for this ISSN

Showing the top 5 of 129 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The problem of bacterial complications post respiratory vira… (10.18527/2500-2236-2018-5-1-12-21)
ORCID
30.10 15
2 Enhancement of the immunogenicity of influenza A virus by th… (10.18527/2500-2236-2018-5-1-48-58)
ORCID
27.85 12
3 Эпидемия гриппа в России в сезон 2014–2015 гг. (10.18527/2500-2236-2015-2-1-19-27)
ORCID
23.86 8
4 Fighting bacterial resistance: approaches, challenges, and o… (10.18527/2500-2236-2017-4-1-31-51)
ORCID
23.86 8
5 Открывая науку: какие возможности дает Open Access? (10.18527/2500-2236-2017-4-1-ii-iv)
Abstract ORCID
23.86 2
6 Enhanced CD8+ T-cell response in mice immunized with NS1-tru… (10.18527/2500-2236-2020-7-1-24-33)
ORCID
23.86 8
7 The use of microarrays for the identification of the origin… (10.18527/2500-2236-2017-4-1-21-30)
ORCID
21.13 6
8 Factors affecting the immunogenicity of the live attenuated… (10.18527/2500-2236-2016-3-1-13-24)
ORCID
17.47 4
9 Effect of triazavirine on the outcome of a lethal influenza… (10.18527/2500-2236-2017-4-1-52-57)
ORCID
17.47 4
10 Cellular immune response in infected mice to NSP protein enc… (10.18527/2500-2236-2019-6-1-28-36)
ORCID
17.47 4
11 Влияние конформационной стабильности гемагглютинина вируса г… (10.18527/2500-2236-2014-1-1-1-11)
ORCID
15.05 3
12 H5N1 influenza vaccine quality is affected by hemagglutinin… (10.18527/2500-2236-2014-1-1-12-26)
ORCID
15.05 3
13 The challenges of creating a universal influenza vaccine (10.18527/2500-2236-2016-3-1-31-41)
ORCID
15.05 3
14 Live poultry vaccines against highly pathogenic avian influe… (10.18527/2500-2236-2018-5-1-22-28)
ORCID
15.05 3
15 First report of the fungus Diaporthe phaseolorum on sunflowe… (10.18527/2500-2236-2018-5-1-65-70)
ORCID
15.05 3
16 Synthesis and study of the antimicrobial activity of nifurox… (10.18527/2500-2236-2019-6-1-10-17)
ORCID
15.05 3
17 Detection and identification of wheat and barley phytopathog… (10.18527/2500-2236-2020-7-1-13-23)
ORCID
15.05 3
18 Two years of experience in hospital surveillance for the sev… (10.18527/2500-2236-2015-2-1-44-55)
ORCID
11.93 2
19 Проблема бактериальных осложнений при респираторных вирусных… (10.18527/2500-2236-2018-5-1-1-11)
ORCID
11.93 2
20 Первая находка гриба Diaporthe phaseolorum на подсолнечнике… (10.18527/2500-2236-2018-5-1-59-64)
ORCID
11.93 2
21 Adaptation of the quantitative PCR method for the detection… (10.18527/2500-2236-2018-5-1-78-83)
ORCID
11.93 2
22 The influenza epidemic in Russia during the 2014–2015 season (10.18527/2500-2236-2015-2-1-56-64)
ORCID
7.53 1
23 Development of the cell-ELISA test for the subtype identific… (10.18527/2500-2236-2015-2-1-65-68)
ORCID
7.53 1
24 Проблема создания универсальной противогриппозной вакцины (10.18527/2500-2236-2016-3-1-1-12)
ORCID
7.53 1
25 Разработка холодоадаптированного реассортантного вируса грип… (10.18527/2500-2236-2016-3-1-42-48)
ORCID
7.53 1
26 A new safe and effective cold-adapted modified live equine i… (10.18527/2500-2236-2016-3-1-68-73)
ORCID
7.53 1
27 Influenza vaccines manufacturing in continuous cell lines: p… (10.18527/2500-2236-2017-4-1-1-9)
ORCID
7.53 1
28 Drug development and open access: approaches and perspective… (10.18527/2500-2236-2018-5-1-29-31)
ORCID
7.53 1
29 Разработка лекарств и открытый доступ: подходы и перспективы (10.18527/2500-2236-2018-5-1-32-35)
ORCID
7.53 1
30 Адаптация метода количественной ПЦР для выявления представит… (10.18527/2500-2236-2018-5-1-71-77)
ORCID
7.53 1
31 Синтез и исследование противомикробной активности производны… (10.18527/2500-2236-2019-6-1-1-9)
ORCID
7.53 1
32 Выявление и идентификация возбудителей бактериальных болезне… (10.18527/2500-2236-2020-7-1-1-12)
ORCID
7.53 1
33 The impact of the global distribution of bats on mortality i… (10.18527/2500-2236-2020-7-1-42-48)
ORCID
7.53 1
34 Mutations designed to modify the NS gene mRNA secondary stru… (10.18527/2500-2236-2021-8-1-1-9)
ORCID
7.53 1
35 Antibiotic susceptibility trends in bacterial isolates from… (10.18527/2024110109)
0.00 4
36 Single intranasal immunization with a high dose of influenza… (10.18527/2024111024)
0.00 4
37 Однократная интраназальная иммунизация высокой дозой гриппоз… (10.18527/2024111024.ru)
0.00 0
38 Construction of oncolytic reporter influenza viral vectors a… (10.18527/202411105118)
0.00 0
39 Конструирование репортерных гриппозных онколитических вектор… (10.18527/202411105118.ru)
0.00 0
40 Multi-pronged surveillance strategies to combat historical s… (10.18527/2024111191121)
Abstract
0.00 0
41 Carbapenem resistance in West Africa: a systematic review (10.18527/2024112556)
0.00 5
42 Diseases caused by human T-lymphotropic virus type 1 (HTLV-1… (10.18527/2024115769)
0.00 3
43 Заболевания, ассоциированные с Т-лимфотропным вирусом типа 1… (10.18527/2024115769.ru)
0.00 0
44 UniFluVec influenza vector induces heterosubtypic protection… (10.18527/2024117079)
0.00 3
45 Malaria and neurological complications: intersecting mechani… (10.18527/2024118096)
0.00 0
46 Antimicrobial peptides modulate lipopolysaccharide-induced g… (10.18527/20241197104)
0.00 1
47 Unravelling vancomycin resistance in newly emerging Enteroco… (10.18527/2025121104112)
0.00 0
48 Priority pathogens of fungal and bacterial infections: devel… (10.18527/2025121116)
0.00 0
49 Приоритетные возбудители грибковых и бактериальных инфекций:… (10.18527/2025121118.ru)
0.00 0
50 Chemical characterization of Dichrostachys cinerea extracts… (10.18527/20251211929)
0.00 0